A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) From Unrelated Donors in Patients With Hematologic Malignancies (BMT CTN #0604).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Cyclophosphamide; Fludarabine; Granulocyte colony-stimulating factors; Mycophenolate mofetil
- Indications Burkitt's lymphoma; Graft-versus-host disease; Leukaemia; Lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
Most Recent Events
- 27 Oct 2017 Biomarkers information updated
- 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2013 Planned End Date changed from 1 Mar 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.